Overview
Find detailed information on a selected clinical trials for Acute Lymphoblastic Leukemia – Therapy for New Diagnosis Very High Risk Disease at Cincinnati Children's Hospital Medical Center.
There are two versions of some of the trials. While they contain the same basic information, one version is geared toward healthcare professionals and the other is geared toward families.
| Trial | Healthcare Professional Version | Family-Friendly Version |
|---|
| AALL0232: High Risk B-precursor Acute Lymphoblastic Leukemia |
Professional |
Family-Friendly |
| AALL0631: A Phase III Study of Risk Directed Therapy for Infants with Acute Lymphoblastic Leukemia: Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibition (CEP-701, Lestaurtinib; IND#76431; NSC#617807) |
Professional |
Not Available |
